Activating BRAF V600E mutation in aggressive pediatric Langerhans cell histiocytosis: demonstration by allele-specific PCR/direct sequencing and immunohistochemistry G Mehes, G Irsai, J Bedekovics, L Beke, F Fazakas, T Rózsa, C Kiss The American journal of surgical pathology 38 (12), 1644-1648, 2014 | 63 | 2014 |
Thyroid carcinoma coexisting with Hashimoto’s thyreoiditis: clinicopathological and molecular characteristics clue up pathogenesis C Molnár, S Molnár, J Bedekovics, A Mokánszki, F Győry, E Nagy, ... Pathology & Oncology Research 25, 1191-1197, 2019 | 54 | 2019 |
Platelet derived growth factor receptor-beta (PDGFRβ) expression is limited to activated stromal cells in the bone marrow and shows a strong correlation with the grade of … J Bedekovics, A Kiss, L Beke, K Károlyi, G Méhes Virchows Archiv 463, 57-65, 2013 | 27 | 2013 |
Circulating cell-free DNA-based comprehensive molecular analysis of biliary tract cancers using next-generation sequencing SL Csoma, J Bedekovics, G Veres, A Árokszállási, C András, G Méhes, ... Cancers 14 (1), 233, 2022 | 24 | 2022 |
Pattern of MEF2B expression in lymphoid tissues and in malignant lymphomas D Krenács, Z Borbényi, J Bedekovics, G Méhes, E Bagdi, L Krenács Virchows Archiv 467, 345-355, 2015 | 19 | 2015 |
Retinol saturase knock-out mice are characterized by impaired clearance of apoptotic cells and develop mild autoimmunity Z Sarang, T Sághy, Z Budai, L Ujlaky-Nagy, J Bedekovics, L Beke, ... Biomolecules 9 (11), 737, 2019 | 17 | 2019 |
Comparative analysis of multicolor flow cytometry and immunohistochemistry for the detection of disseminated tumor cells E Szánthó, B Kárai, G Ivády, J Bedekovics, I Szegedi, M Petrás, G Ujj, ... Applied Immunohistochemistry & Molecular Morphology 26 (5), 305-315, 2018 | 15 | 2018 |
Programmed death-ligand 1 (PD-L1) expression in thymic epithelial tumors J Bedekovics, L Beke, A Mokanszki, S Szilagyi, G Mehes Applied Immunohistochemistry & Molecular Morphology 28 (1), 1-9, 2020 | 14 | 2020 |
A single‐tube flow cytometric procedure for enhancing the diagnosis and prognostic classification of patients with myelodysplastic syndromes B Kárai, J Bedekovics, ZS Miltényi, L Gergely, L Szerafin, A Ujfalusi, ... International Journal of Laboratory Hematology 39 (6), 577-584, 2017 | 11 | 2017 |
Hypoxia‐related carbonic anhydrase IX expression is associated with unfavourable response to first‐line therapy in classical Hodgkin's lymphoma G Méhes, O Matolay, L Beke, M Czenke, Á Jóna, Z Miltényi, Á Illés, ... Histopathology 74 (5), 699-708, 2019 | 10 | 2019 |
Mitotic index determined by phosphohistone H3 immunohistochemistry for precise grading in follicular lymphoma J Bedekovics, G Irsai, K Hegyi, L Beke, L Krenács, L Gergely, G Méhes Applied Immunohistochemistry & Molecular Morphology 26 (8), 579-585, 2018 | 10 | 2018 |
Carbonic anhydrase IX (CAIX) expressing hypoxic micro-environment hampers CD8+ Immune cell infiltrate in breast carcinoma P Juhász, D Hasulyó, J Bedekovics, L Beke, N Kacsala, M Török, ... Applied Immunohistochemistry & Molecular Morphology 31 (1), 26-32, 2023 | 8 | 2023 |
Quantitative analysis of carbonic anhydrase IX uncovers hypoxia-related functional differences in classical Hodgkin Lymphoma subtypes O Matolay, L Beke, A Gyurkovics, M Francz, G Varjasi, L Rejtő, Á Illés, ... International Journal of Molecular Sciences 20 (14), 3463, 2019 | 8 | 2019 |
Platelet‐derived growth factor receptor β (PDGFR β) immunohistochemistry highlights activated bone marrow stroma and is potentially predictive for fibrosis progression in … G Méhes, A Tzankov, K Hebeda, I Anagnostopoulos, L Krenács, ... Histopathology 67 (5), 617-624, 2015 | 8 | 2015 |
Deep molecular and in silico protein analysis of p53 alteration in myelodysplastic neoplasia and acute myeloid leukemia K Madarász, JA Mótyán, J Bedekovics, Z Miltényi, A Ujfalusi, G Méhes, ... Cells 11 (21), 3475, 2022 | 4 | 2022 |
Image analysis of platelet derived growth factor receptor‐beta (PDGFRβ) expression to determine the grade and dynamics of myelofibrosis in bone marrow biopsy samples J Bedekovics, S Szeghalmy, L Beke, A Fazekas, G Méhes Cytometry Part B: Clinical Cytometry 86 (5), 319-328, 2014 | 4 | 2014 |
Treatment of acute myeloid leukemia–a single center experience (2007–2013) A Selmeczi, M Udvardy, Á Illés, B Telek, A Kiss, P Batár, G Reményi, ... Orvosi Hetilap 155 (17), 653-658, 2014 | 4 | 2014 |
Molecular analysis of cell-free DNA in peripheral blood in biliary tract malignancies SL Csoma, J Bedekovics, G Veres, A Árokszállási, C András, G Méhes, ... Orvosi Hetilap 163 (50), 1982-1991, 2022 | 3 | 2022 |
Distinct Dynamics of Mitotic Transition in B-Cell Lymphoma and Reactive B-Cell Lymphoproliferations Determined by H3S10 Phosphohistone Immunolabeling G Méhes, K Hegyi, R Jobanputra, L Beke, G Vereb, J Bedekovics Pathobiology 84 (5), 243-250, 2017 | 3 | 2017 |
Mutant KRAS status is associated with increased KRAS copy number imbalance: a potential mechanism of molecular heterogeneity O Dócs, K Hegyi, A Mokánszky, A Mónusné, L Beke, C András, ... Pathology & Oncology Research 23, 417-423, 2017 | 3 | 2017 |